The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 08, 2016

Filed:

Oct. 09, 2014
Applicant:

Acetylon Pharmaceuticals, Inc., Boston, MA (US);

Inventors:

John H. van Duzer, Georgetown, MA (US);

Ralph Mazitschek, Belmont, MA (US);

Simon Stewart Jones, Harvard, MA (US);

Min Yang, Newton, MA (US);

David Lee Tamang, Watertown, MA (US);

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/506 (2006.01); C07D 417/12 (2006.01); C07D 401/12 (2006.01); C07D 401/14 (2006.01); C07D 239/42 (2006.01);
U.S. Cl.
CPC ...
C07D 417/12 (2013.01); C07D 239/42 (2013.01); C07D 401/12 (2013.01); C07D 401/14 (2013.01); A61K 31/506 (2013.01);
Abstract

Provided herein are compounds, pharmaceutical compositions comprising such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with HDAC activity, particularly diseases or disorders that involve activity of HDAC1, HDAC2, and/or HDAC6. Also provided herein are methods for inhibiting migration of a neuroblastoma cell, inducing maturation of a neuroblastoma cell, and altering cell cycle progression of a neuroblastoma cell comprising administering to the cell a therapeutically effective amount of a HDAC1, HDAC2, and/or HDAC6 selective inhibitor or a pharmaceutically acceptable salt thereof.


Find Patent Forward Citations

Loading…